Works matching IS 00070920 AND DT 2011 AND VI 105 AND IP 1


Results: 29
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy.

    Published in:
    2011
    By:
    • Garrett, C. R.;
    • Siu, L. L.;
    • El-Khoueiry, A.;
    • Buter, J.;
    • Rocha-Lima, C. M.;
    • Marshall, J.;
    • LoRusso, P.;
    • Major, P.;
    • Chemidlin, J.;
    • Mokliatchouk, O.;
    • Velasquez, L.;
    • Hayes, W.;
    • Feltquate, D.;
    • Syed, S.;
    • Ford, S.;
    • Kollia, G.;
    • Galbraith, S.;
    • Nuyten, D. S. A.
    Publication type:
    journal article
    23
    24
    25
    26
    27
    28
    29